Company intelligence / Profile preview

Metrochem API

Hyderabad, Telangana, Indiametroapi.com ↗

Ownership: Private
Employees: ~2500
Development stage: Other

Overview

Metrochem API manufactures a wide range of commercialized APIs and intermediates for global pharmaceutical markets. The company holds process patents and has received regulatory approvals from USFDA, WHO-GMP, COFEPRIS, KFDA among others. It was awarded India Pharma Bulk Drug Company of the Year in 2020 by the Government of India for its contributions to bulk drug manufacturing. No clinical trial results are reported as it does not develop proprietary drugs.

Therapeutic areas: EndocrinologyImmunologyHematologyGastroenterologyCardiovascular
Modalities: Small moleculePellets (Semi finished Formulations)IntermediatesFine and Specialty Chemicals
Industry: Contract Manufacturing Organization

Partnerships

Not specifically disclosed; operates globally with pharma partners through supply agreements.

Beyond the preview

Go deeper on Metrochem API.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Metrochem API.

Explore the full profile